International
Feb. 11, 2011
Foreign Drug Licensing Next Front in War on Health Care Costs
To combat high drug prices, India may issue compulsory licenses, which let generic manufacturers sell medications without consent from the patent holder. Legal experts fear other countries will follow suit in the war on health care costs.
Daily Journal Staff Writer
In the global war on health care costs, drug patent protection has become a new battleground.
The biggest fight over drug makers' intellectual property is brewing in India, where the government is considering giving generic drug manufacturers the right to sell low-cost versions of brand-name medications without consent from the pharmaceutical firms that own the patents. These allowances, called c...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In